Thoracic Weekly 暂无符合条件的文献。
Adjuvant alectinib versus chemotherapy in resected ALK-positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial.
Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.
Therapeutic evolution: Adoption of newly approved systemic therapies in resected stage IB-IIIA NSCLC in the United States.
Combined low-dose thoracic computed tomography and circulating tumor cell screening for cancer in ever smokers with peripheral arterial disease: A prospective multicenter cohort study.
Elevated Pre-Treatment Serum Interleukin-10 Levels Predict Poor Overall Survival in Esophageal Cancer.
Neutrophil Extracellular Trap-Derived DNA Activates the ITGB1/FAK Pathway to Promote Lung Adenocarcinoma Metastasis.
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial.
Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.
PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.
Local Regrowth After Neoadjuvant Chemoradiotherapy and Active Surveillance for Esophageal Cancer: An Analysis of Surgical Specimens From the SANO Trial.
Surgical stabilization of rib fractures in adult trauma patients with flail chest with or without severe traumatic brain injury: A national analysis.
Efficacy and safety of adding induction therapy for unresectable NSCLC receiving cCRT and consolidation immunotherapy: A retrospective study.
The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.
RaFiST: a radiomics model for non-invasive stratification of tumor fibrosis and prognostic prediction in non-small cell lung cancer.
Patient-derived organoids support radiotherapy response and recurrence risk prediction in esophageal squamous cancer.
Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy.
Molecular heterogeneity and differential metabolic signatures in thymic adipocytes.
Correlation Between Lower Lobe Dose Parameters and Radiation Pneumonitis in Definitive Radiation Therapy for Non-Small Cell Lung Cancer.
The Multimodal Pretraining Framework CarHE Predicts Spatial Transcriptomics in Tumors from Routine Pathology Images.
Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.
Intraoperative Adverse Events in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Incidence, Management, and Impact on Surgical Outcomes.
Impact of lung cancer discovery mode on cancer outcomes: data from the KBP-2020-CPHG study.
Current Status and Future Perspectives of Robotic Surgery for Esophagogastric Cancer in Asia.
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.
68Ga-NK224 PET/CT Reveals Intra- and Intertumoral Heterogeneity of PD-L1 in Non-Small Cell Lung Cancer.
Determinants of Failure to Rescue After Pulmonary Resection for Lung Cancer: Insights From a National Inpatient Sample.
Role of Lung Marking in the Age of Sublobar Resection.
Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling.
Distinct spatial immune microenvironment features of different EGFR mutation subtypes in early-stage lung adenocarcinoma.
Multidisciplinary Team Care for Early-Stage Lung Cancer in Low- and Middle-Income Countries and Emerging Economies: Current Position and Call for Action.
Lung Cancer Risk for Patients Undergoing Cardiac Chest CT: Identification of a New High Risk Population for Lung Cancer Screening.
A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.
CTPS1 promotes lung adenocarcinoma progression as a targetable vulnerability.
Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study.
Clinical Outcomes of Neoadjuvant Chemoimmunotherapy Versus Chemoradiation Combined with Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.
Salvage Surgery After Proton Beam-Based Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: A Case Series Study.
DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy.
ΔAverage of long and short axis diameter on non-contrast CT is associated with major pathological response to neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Integrative multi-omics reveals a prognostic and therapeutic landscape of synthetic lethality-associated signatures in lung adenocarcinoma.
Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC.
KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.
Cigarette Smoke Extract Promotes Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer by Upregulating PRMT6.
AI-driven dual-task prediction model for co-stratifying efficacy and toxicity in NSCLC immunotherapy.
Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors.
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.
Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer.
From probe to prodrug: immunoproteasome activity as a trigger for disease-selective therapeutics.
Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study.
Baseline IL-6, IL-8, IFN-ω, and perforin as prognostic biomarkers in immune checkpoint inhibitor-treated metastatic non-small cell lung cancer.
Predictors of prolonged hospital stay in patients with lung cancer undergoing sublobar resection.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.
Development and validation of machine learning diagnostic models integrating clinical, CT, and laboratory features to differentiate lung cancer from pulmonary tuberculosis in patients with solitary pulmonary nodules: a single-center retrospective study.
Neoadjuvant befotertinib plus vorolanib in resectable stage II-IIIB EGFR-mutant NSCLC: a study protocol for the prospective, single-arm phase I/II trial.
Association of symptoms at diagnosis with prognosis in patients with surgically treated stage I non-small cell lung cancer: a retrospective cohort analysis of a prospectively maintained registry.
Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review.
Tertiary lymphoid structures predict the neoadjuvant chemoimmunotherapy response of stage III non-small cell lung cancer.
Real-world analysis in patients with limited-stage small-cell lung cancer who received durvalumab after concurrent chemoradiotherapy.
FOXA1 drives chemoresistance through activating Wnt pathway in small cell lung cancer.
Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study).
Deciphering lung cancer at high resolution: a narrative review of applications of single-cell and spatial transcriptomics sequencing.
Decreasing Length of Stay for Pectus Excavatum Repair by Implementing an ERAS Protocol.
PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.
Elevated serum neuron-specific enolase as an indicator of poor chemo-immunotherapy outcomes and reduced CD8-positive lymphocyte infiltration in small-cell lung cancer: a retrospective cohort study.
Promising benefits of MET inhibition combined with EGFR/ALK tyrosine kinase inhibitor in heavily treated non-small cell lung cancer patients with EGFR-mutant/ALK rearrangement and MET overexpression: a retrospective cohort study.
A retrospective cohort study integrating invasive mucinous adenocarcinoma into the IASLC grading system for lung adenocarcinoma.
Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC.
Best supportive care in stage I-III non-small cell lung cancer: survival by reason for curative treatment omission in a real-world study population.
Targeted therapeutic strategies for KRAS-G12D-mutant non-small cell lung cancer: a narrative review.
Patterns of Lymph Node Metastases After Multimodality Therapy in Esophageal Carcinoma Treated with Robot-Assisted Minimally Invasive Esophagectomy (RAMIE).
CT-derived abdominal organ volumetrics for predicting recurrence-free and disease-free survival in resected non-small cell lung cancer: a multicenter retrospective cohort study.
Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.
Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study.
Role and clinical significance of VISTA (PD-1H) and PVR (CD155) expression in non-small cell lung carcinoma: a systematic review.
Multiplexed quantitative proteomics in small-cell lung cancer: stage-linked DLL3 distribution and an independent prognostic signal of thymidine phosphorylase.
Longevity-associated FOXO3 genotype mitigates the risk of lung cancer after smoking cessation: a prospective cohort study.
Development and validation of a machine learning model for predicting objective response to PD-1 inhibitors in lung cancer patients.
Blood metabolomic signatures linking air pollution to lung cancer in the Cancer Prevention Studies.
Structured triage of incidental findings in lung cancer screening: Outcomes from a UK programme.
A high-resolution circulating metabolic atlas of lung adenocarcinoma progression supports early and accurate diagnosis.
Contrast-enhanced CT Radiomics for High-Grade Pattern Identification and Prognostic Stratification in Lung Adenocarcinoma with Consolidation-to-Tumor Ratio of 25% or More.
Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).
Endogenous CD155 drives metabolic reprogramming via PI3K/AKT/HIF-1α-glycolysis axis to mediate anti-PD-1 resistance in non-small cell lung cancer.
Lung Transplant for Stage IV NSCLC-A Promising Intervention in a Scarce-Resource Environment.
ENDOCUT Q coagulation fraction is associated with esophageal stricture after endoscopic submucosal dissection.
Fruit and Vegetable Intake in Relation to the Risks of Lung, Colorectal, Stomach, and Overall Cancers in China: A Prospective Cohort Study.
Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real-World Study.
Mycoplasma infection drives EGFR-TKI resistance through convergent transcriptomic reprogramming in non-small cell lung cancer.
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.
Real-world evaluation of the christie symptom inventory-lung cancer (CSI-lung) electronic patient-reported outcome measure: validity, reliability, responsiveness, and patient experiences.
Incidental detection of cancers during population-based endoscopic gastric cancer screening in Japan.
Clinical characteristics and management of Li-Fraumeni syndrome-associated lung cancer.
The evolution of a novel technique for treatment of intercostal hernias and restoration of costal margin rupture.
Immune signatures in NSCLC associated pleural effusions and implications for prognosis.
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.
Post-Treatment Imaging in Lung Cancer Patients: Adherence to Surveillance Guidelines Is Associated with Improved Survival in a Longitudinal Cohort.
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort.
DAFNet: A multi-modal deep learning model based on whole-lung CT for the automated prediction of the air space spread of lung adenocarcinoma.
The effect of cigar, cigarillo and pipe smoking on lung cancer risk and screening eligibility.
De-escalation of Adjuvant EGFR-TKI in Stage IB EGFR-Mutated Non-small-cell Lung Cancer: A Real-World Study.
Essentiality-driven prediction of anticancer drug responses in preclinical and clinical contexts.
CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B (N2) Non-Small Cell Lung Cancer: Surgical Outcomes.
Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.
Loss of NCCRP1 overcomes immune evasion in lung adenocarcinoma.
Coordinated microbial-inflammatory associations in never-smoking lung cancer.
M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.
Systematic review and meta-analysis of FDG PET-CT for nodal staging of part-solid lung adenocarcinomas.
Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration.
Diabetes Increases Immunotherapy-Related Toxicity but Not Efficacy in Metastatic Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.
Exercise Modulates Adiposity-induced Immune Dysfunction in NSCLC and Non-tumor-Bearing Lungs: Implications for Lung Cancer Therapy and Interception.
RanBP2 promotes ferroptosis resistance and compromises therapeutic response by stabilizing SLC7A1 through LRSAM1 SUMOylation and ubiquitination in lung adenocarcinoma.
Enhancing venous thromboembolism risk prediction after immunotherapy for lung cancer.
XunZi, an AI biologist, reveals disease-modifying targets.
The RAB32-USP13 axis facilitates TOM40 mitochondrial localization to promote non-small cell lung cancer progression.
Aumolertinib Versus Osimertinib as First-Line Treatment for EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Multicenter Study.
Chronic Stress-Induced m7G Cap Modification of ADRB2 Dysregulates the Pentose Phosphate Pathway to Promote Esophageal Squamous Cell Carcinoma Progression.
Examining the role of extrachromosomal DNA in lung cancer.
Phase Separation of ZBED2 Stabilizes ILK to Drive Metastasis and Immune Evasion in Esophageal Squamous Cell Carcinoma.
CHAF1A promotes RAD51 loading and homologous recombination to drive tumor radioresistance.
SCLC humanized mice identify T cell infiltration phenotypes in response to combination immune-radiation therapies.
ADAR1 regulates radiosensitivity in ESCC through cIAP2-NF-κB signaling and C16orf46 editing.
BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer.
Tumor-distal mediastinal lymph nodes harbor tumor-related progenitor exhausted T cells in lung cancer after neoadjuvant chemoimmunotherapy.
Uncovering ectopic GC-like niches for tumor reactive lymphocyte priming in lung adenocarcinoma using Stereo-XCR-seq.
Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study.
PER1-related inflammatory signaling links night shift exposure to lower lung function in coal miners.
The limits of pooled evidence in early-stage NSCLC: are we comparing treatments or patients?
A fermented milk drink containing Lactobacillus casei strain Shirota modulates the esophageal microbiome composition in Barrett's esophagus.
Endoscopic histological validation of clinical complete response after neoadjuvant chemoimmunotherapy for esophageal cancer.
Lung Cancer's Social Identity: Historical Insights to Improve Collaborative Decision-Making for Surgery.
Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk.
Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.
One PPI may not fit all-prevalence of CYP2C19 phenotypes in patients with Barrett's esophagus.
Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study.
Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer.
Age-Stratified Outcomes of the Nuss Procedure for Pectus Excavatum: Challenging the Association Between Younger Age and Inferior Correction.
Evacuation of hemothorax during SSRF: Does the technique influence the outcome?
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018-2022: A Nationwide Analysis in Japan.
The Prognostic Impact of Lymph Node Yield Upon Survival in Esophageal Cancer Broken Down by Neoadjuvant Strategy: A Multicenter European Cohort Study.
IMPACT OF 2-SITE CRYOABLATION ON PAIN CONTROL AFTER THE NUSS PROCEDURE.
ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib-Treated NSCLC.
Risk factors of cervical anastomotic stricture after esophagectomy detected by early postoperative endoscopy.
Salvage endoscopic submucosal dissection via a continuous irrigation method for locally recurrent esophageal cancer after photodynamic therapy.
Survival Differences Among Non-pCR Patients with Distinct Pathological Outcomes After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
The Optimal Lung Cancer Ct Screening Strategy: A Cost-Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions.
Same Diagnosis, Different Disease: Why Sex Matters in Lung Cancer.
HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing RPS15.
Dual targeting of BCL-XL and MCL-1 exposes a rapid and exploitable apoptotic vulnerability in non-small cell lung cancer.
Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study.
The Impact of EHR Alerts to Correct Smoking History on Lung Cancer Screening: A Randomized Controlled Quality Improvement Initiative.
Evaluating health-related quality of life questionnaires in capturing common symptomatic adverse events in non-small cell lung cancer.
Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants.
Contemporary Pulmonary Nodule Evaluation and Management in the U.S.: A Mixed Methods Study.
Validation of a Text-Mining Tool for Extracting Routine Clinical Care Data in Early-Stage Resectable Non-Small Cell Lung Cancer.
SEZ6-Targeted PET Imaging and Alpha-Particle Radioimmunotherapy is Effective for Detection and Treatment of Small Cell Lung Cancer.
Lung cancer in interstitial lung disease: a matched case-control and cohort analysis.
Return-To-Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study.
Tool In Lesion- But Still Off Target: A Call of Concern for Lung Cancer Screening.
Beyond Pathological Complete Response: Long-term Outcomes in Esophageal and Esophagogastric Junction Adenocarcinoma After Multimodal Therapy-A Systematic Review and Individual Patient-Data Meta-Analysis.
Reduced Risk of Lung Cancer Associated with Sodium-Glucose Cotransporter-2 Inhibitors in Patients with COPD and Type 2 Diabetes Mellitus.
The addition of radial endobronchial ultrasound to electromagnetic navigation bronchoscopy: the NEBULA study - a randomised controlled trial.
Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies.
Neoadjuvant chemotherapy and surgery-based treatment with selective adjuvant chemotherapy for cT2N0 esophageal squamous cell carcinoma: a multicenter retrospective study.
Clinical Relevance of BACH1 Expression in Non-Small Cell Lung Cancer.
The phase separation of ZC3H18 transcriptionally activates LDHA and forms lactylation-mediated positive feedback loop to promote tumorigenesis of lung cancer.
Prediction of spread through air spaces with biopsy specimens in early-stage adenocarcinoma of the lung.
Development and validation of a risk-stratification model for individualized management of leptomeningeal metastases in EGFR- mutant NSCLC (LM-Index).
Integrating habitat-based radiomics, 3D deep learning, and clinical variables for detection of early-stage esophageal squamous cell carcinoma on noncontrast chest CT: A multicenter study.
Spread through air spaces in multiple synchronous bilateral primary lung cancer: prognostic implications in a surgical cohort.
Clinicopathological and prognostic validation of pulmonary carcinoid/NET G3: evidence for a distinct subgroup of well-differentiated neuroendocrine neoplasms.
Improving follow-up of incidental pulmonary nodules in the emergency department using an artificial intelligence-supported workflow.
Log Odds of Positive Lymph Nodes Improves Risk Stratification for Early Recurrence and Survival After Radical Esophagectomy for cT3 Esophageal Squamous Cell Carcinoma.
Phase II Multicenter Clinical Trial of Intraoperative Molecular Imaging with Abenacianine During Lung Cancer Surgery.
Impact of immunotherapy on overall survival and healthcare costs in advanced/metastatic lung cancer: A real-world study in France.
Risk of Primary Lung Cancer in Women with Personal History of Breast Cancer and Subsequent Treatment Modality in an Integrated Health System.
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Circular RNAs in esophageal squamous cell carcinoma: What do we know so far?
Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer.
Long noncoding RNA MNX1-AS1 mediated regulation of one-carbon metabolism by preventing CACYBP degradation to promote lung cancer progression.
N6-methyladenosine-mediated upregulation of PAICS promotes lung-adenocarcinoma metastasis via the integrin-FAK signaling.
Type 2 diabetes mellitus confers unfavorable short- and long-term outcomes in patients undergoing esophagectomy.
Krüppel-like factor 4 downregulation during esophageal cancer formation facilitates immune evasion and impairs immunotherapy.
Mechanisms and therapeutic targets in distant metastasis of lung adenocarcinoma.
Dynamic versus Standard Vacuum Therapy for Pectus Excavatum: A Comparative Study of Short-Term Treatment Outcomes.
Efficacy and biomarker exploration of anlotinib plus penpulimab in second-line ES-SCLC: Results from the phase 2 ALTER-L041 trial.
Safety-aware AI for NSCLC trial pre-screening: a comparative proof-of-concept study of rule-based, single-agent, and multi-agent approaches.
Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.
Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lung Cancer.
An unusual pulmonary vascular connection encountered during right upper lobectomy.
CT-based Intratumoral Heterogeneity Score for Preoperative Prediction of Lymphovascular Invasion and Prognosis in Lung Adenocarcinoma: A Multicenter Validation and Radiogenomic Interpretation.
A novel MYO5C-ALK fusion in lung adenocarcinoma: limited alectinib response and durable lorlatinib benefit.
Factors Associated With Tracheoplasty in Children With Pulmonary Artery Sling and Congenital Tracheal Stenosis.
Multi-task deep learning model for predicting EGFR mutation status in NSCLC.
Design-Outcome Concordance in Targeted-Therapy trials in Non-Small cell lung cancer: a Meta-Research study.
UHRF1 inhibits cuproptosis in lung adenocarcinoma via promoting FDX1 promoter methylation.
Clinical Utility of Next Generation Sequencing in Concurrent EBUS-TBNA and Liquid Biopsies in NSCLC.
Treatment strategies for postoperative locoregional recurrent esophageal squamous cell carcinoma after curative resection: a narrative review.
COPD is associated with poorer survival in patients with advanced non-small cell lung cancer treated with first-line ICI plus chemotherapy.
Real-world treatments and outcomes in metastatic and recurrent esophageal squamous cell carcinoma in Japan: a retrospective analysis using the Millennial Medical Record database.
Single-Cell Analysis of Residual Esophageal Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy Reveals TFAM-Mediated Immunoregulation in Dendritic Cells.